Skip to main content
. 2014 May 20;24:14002. doi: 10.1038/npjpcrm.2014.2

Table 1. Characteristics of participants with post-bronchodilator spirometry in the two analysed samples.

  2003 Mexico City PLATINO subsample (n=542) 2010 Mexico City survey sample (n=659)
Demographics
 Age group (%)
  40–49 41.5 29.7
  50–59 24.7 34.6
  60–69 18.1 22.5
  70–79 9.4 9.4
  ⩾80 6.3 3.8
 % Men 43.9 41.1
   
Anthropometry, mean (s.d.)
 Height (cm) 156.3 (9.5)) 156.6 (9.1)
 Weight (kg) 69.5 (13.6) 71.6 (13.9)
 Body mass index (kg/m2) 28.4 (4.9) 29.2 (5.1)
 % Obese 29.5 37.0
   
Respiratory symptoms, %
 Cough and phlegm on most days for at least 3 months per year 4.2 4.4
 Attack of wheezing with shortness of breath in the past 12 months 3.3 2.4
   
Medical diagnosis, %
 Asthma 5.0 4.9
 COPD 2.4 0.8
 Tuberculosis 0.7 0.9
Exposures
 Pack-years of cigarette smoking, %
  Never smoker 57.2 56.2
  1–9 28.0 28.7
  ⩾10 14.8 15.2
 % who worked in a dusty job for >1 year 46.7 38.5
 Years exposed to wood smoke from cooking, mean (s.d.) 5.5 (9.8) 5.2 (9.0)
COPD prevalence, % (n)
 GOLD stages 1–4 9.0 (49) 3.6 (24)
 GOLD stages 2–4 3.5 (19) 1.8 (12)
 FEV1/FEV6 <LLN 4.1 (22) 2.6 (17)

Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; FEV6, forced expiratory volume in 6 s; GOLD, Global Initiative for Chronic Obstructive Lung Disease; LLN, lower limit of normal.